FDA Approved: REYATAZ — Original Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approves REYATAZ (atazanavir) under its original NDA filed by E.R. Squibb & Sons, L.L.C. for the treatment of HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• REYATAZ (atazanavir)

Snippet

ORIG AP for REYATAZ (ATAZANAVIR)